Product Code: GVR-2-68038-422-2
Extracellular Matrix Patches Market Growth & Trends:
The global extracellular matrix patches market size is expected to reach USD 51.8 million by 2030, registering a CAGR of 7.8% during the forecast period, according to a new report by Grand View Research, Inc.. Increasing prevalence of cardiovascular diseases, the rising number of trauma surgeries, and the growing adoption of ECM patches among healthcare providers are some of the key drivers for this market. Recent development of advanced ECM patches for soft tissue repair and wound healing procedures is also expected to positively impact market growth.
The surging number of hernia and pelvic restoration surgeries is also propelling demand for ECM patches in healing processes. Moreover, these patches offer greater biocompatibility, durability, and pliability than synthetic patches, which is expected to drive demand in the market. Favorable reimbursement support by governments around the world is also expected to boost the adoption and acceptance of these patches in the market.
The rising number of research activities for the development of extracellular matrix patches enables an expansion in applications, which in turn, drives the market. In addition, rising government initiatives toward improvement in healthcare infrastructure and increasing healthcare expenditure in developing countries are positively influencing the market growth. However, the high cost of these patches is a significant factor that can lower the adoption of these patches in lower- and middle- income countries.
Extracellular Matrix Patches Market Report Highlights:
- ECM patches for soft tissue repair emerged as the largest application segment in terms of revenue in 2022, owing to the rising number of hernia repair and trauma surgeries*
- ECM patches derived from porcine accounted for the largest revenue share in 2022 based on raw material owing to several benefits of porcine over other sources, such as reduction in scar formation, durability, and pliability
- In terms of geography, North America accounted for the largest revenue share in 2022 and Asia Pacific is expected to exhibit the fastest growth rate over the forecast period
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Application
- 1.1.2. Raw material
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Application outlook
- 2.2.2. Raw material outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Extracellular Matrix Patches Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
- 3.4. Extracellular Matrix Patches Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
Chapter 4. Extracellular Matrix Patches Market: Application Estimates & Trend Analysis
- 4.1. Extracellular Matrix Patches Market, Key Takeaways
- 4.2. Extracellular Matrix Patches Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Cardiac Repair
- 4.3.1. Cardiac repair market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Vascular Repair & Reconstruction
- 4.4.1. Vascular repair & reconstruction market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5. Pericardial Repair
- 4.5.1. Pericardial repair market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6. Dural Repair
- 4.6.1. Dural repair market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.7. Soft Tissue Repair
- 4.7.1. Soft tissue repair market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.8. Wound Healing
- 4.8.1. Wound healing market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Extracellular Matrix Patches Market: Raw Material Estimates & Trend Analysis
- 5.1. Extracellular Matrix Patches Market, Key Takeaways
- 5.2. Extracellular Matrix Patches Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Bovine
- 5.3.1. Bovine market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Porcine
- 5.4.1. Porcine market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Others
- 5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Extracellular Matrix Patches Market: Regional Estimates & Trend Analysis
- 6.1. Regional Outlook
- 6.2. Extracellular Matrix Patches Market by Region: Key Takeaway
- 6.3. North America
- 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.2. U.S.
- 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.3. Canada
- 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4. Europe
- 6.4.1. U.K.
- 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.2. Germany
- 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.3. France
- 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.4. Italy
- 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.5. Spain
- 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.6. Sweden
- 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.7. Norway
- 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.8. Denmark
- 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5. Asia Pacific
- 6.5.1. Japan
- 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.2. China
- 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.3. India
- 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.4. Australia
- 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.5. Thailand
- 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.6. South Korea
- 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6. Latin America
- 6.6.1. Brazil
- 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.2. Mexico
- 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.3. Argentina
- 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7. MEA
- 6.7.1. Saudi Arabia
- 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.2. South Africa
- 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.3. UAE
- 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.4. Kuwait
- 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Market Participant Categorization
- 7.2.1. Cook Group
- 7.2.1.1. Company overview
- 7.2.1.2. Financial performance
- 7.2.1.3. Product benchmarking
- 7.2.1.4. Strategic initiatives
- 7.2.2. Coloplast Group
- 7.2.2.1. Company overview
- 7.2.2.2. Financial performance
- 7.2.2.3. Product benchmarking
- 7.2.2.4. Strategic initiatives
- 7.2.3. Smith & Nephew
- 7.2.3.1. Company overview
- 7.2.3.2. Financial performance
- 7.2.3.3. Product benchmarking
- 7.2.3.4. Strategic initiatives
- 7.2.4. Koninklijke DSM N.V.
- 7.2.4.1. Company overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. MTF Biologics
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic initiatives
- 7.2.6. Boston Scientific Corporation
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. Medtronic
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. Baxter
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives
- 7.2.9. Aziyo Biologics
- 7.2.9.1. Company overview
- 7.2.9.2. Financial performance
- 7.2.9.3. Product benchmarking
- 7.2.9.4. Strategic initiatives
- 7.2.10. Admedus Ltd.
- 7.2.10.1. Company overview
- 7.2.10.2. Financial performance
- 7.2.10.3. Product benchmarking
- 7.2.10.4. Strategic initiatives